Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 4

Nephrogenic Diabetes Insipidus in a Neonate

Pages
[569]–571
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case is presented to keep the diagnosis of NDI in mind in patients with severe hypernatremic dehydration in the neonatal period and to emphasize the prevention of comorbid conditions with early diagnosis and prompt treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nephrogenic diabetes insipidus (NDI) is a rare disorder that develops as a result of resistance to antidiuretic hormone and is characterized by polyuria and polydipsia, high serum osmolality, and low urine osmolality.
📊
Key Findings & Data:In physical examination, collapse of anterior fontanel, decreased mucosal wetness, and impaired turgor tonus were observed.
💡
Conclusion & Impact:This case is presented to keep the diagnosis of NDI in mind in patients with severe hypernatremic dehydration in the neonatal period and to emphasize the prevention of comorbid conditions with early diagnosis and prompt treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Nephrogenic diabetes insipidus (NDI) is a rare disorder that develops as a result of resistance to antidiuretic hormone and is characterized by polyuria and polydipsia, high serum osmolality, and low urine osmolality. Eight-day-old male patient applied with the complaints of excessive sucking and drowsiness. In physical examination, collapse of anterior fontanel, decreased mucosal wetness, and impaired turgor tonus were observed. Polyuria, hypernatremia, high blood osmolality, and low urine osmolality were detected. After initiation hydrochlorothiazide treatment, the clinical and laboratory findings improved. In genetic analysis, hemizygous mutation was detected in the AVPR2 gene c.299_319del21bp (p.100_107deIRPTASV) which was previously described in the literature. Early diagnosis and treatment of NDI has vital importance and can prevent mental retardation and growth retardation due to possibility of recurrent dehydration and hypernatremia. This case is presented to keep the diagnosis of NDI in mind in patients with severe hypernatremic dehydration in the neonatal period and to emphasize the prevention of comorbid conditions with early diagnosis and prompt treatment.

🔖

Cite This Article

ÇELİK, M., KARA, M. A. (2021). Nephrogenic Diabetes Insipidus in a Neonate. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 4, [569]–571. https://ajindex.com/articles/398698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, et al. Diabetes insipidus--diagnosis and management. Horm Res Paediatr 2012;77:69–84
  2. Guarino S, Diplomatico M, Marotta R, Pecoraro A, Furlan D, Cerrone L, et al. Nephrogenic diabetes insipidus in childhood: assessment of volume status and appropriate fluid replenishment. Pediatr Emerg Care 2020;36:e402–4
  3. Knoers N. Nephrogenic diabetes insipidus. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, editors. Source Gene Reviews. Seattle: University of Washington, Seattle; 1993-2018
  4. Kavanagh C, Uy NS. Nephrogenic diabetes insipidus. Pediatr Clin North Am 2019;66:227–34
  5. Bonfrate L, Procino G, Wang DQ, Svelto M, Portincasa P. A novel therapeutic effect of statins on nephrogenic diabetes insipidus. J Cell Mol Med 2015;19:265–82
  6. Bouley R, Lu HA, Nunes P, Da Silva N, McLaughlin M, Chen Y, et al. Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration. J Am Soc Nephrol 2011;22:59–72
  7. Assadi F, Sharbaf FG. Sildenafil for the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 2015;42:65–9
  8. Namatame-Ohta N, Morikawa S, Nakamura A, Matsuo K, Nakajima M, Tomizawa K, et al. Four Japanese patients with congenital nephrogenic diabetes insipidus due to the AVPR2 mutations. Case Rep Pediatr 2018;2018:6561952.